| Date | Title | Description | |
|---|---|---|---|
| 22 Feb 2022 | On buy-back programmes | ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022. | Download |
| 16 Feb 2022 | On business and financial situation | Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years | Download |
| 03 Nov 2021 | On buy-back programmes | The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. | Download |
| 16 Jul 2021 | On Corporate Governance | ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company | Download |
| 22 Jun 2021 | On significant placements in financial instruments | Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 06 May 2026 | Announcement of general shareholders’ meeting | The Company announces the calling of its 2026 Ordinary General Shareholder´s Meeting. | Download |
| 01 Apr 2026 | On corporate transactions | ROVI announces the closing of the Asset Purchase Agreement entered into in September 2025 for the acquisition of a pharmaceutical manufacturing facility in Phoenix, Arizona (USA) | Download |
| 25 Feb 2026 | Annual Corporate Governance Report | The Company submits the Annual Corporate Governance Report for fiscal year 2025. | Download |
| 25 Feb 2026 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2025 annual report regarding remuneration of the members of the Board of Directors. | Download |
| 18 Nov 2025 | On business and financial situation | The Company releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 20 Feb 2018 | Información sobre resultados | ROVI releases the presentation related to the full year 2017 results | Download |
| 20 Feb 2018 | Información sobre resultados | ROVI releases the press release related to the full year 2017 results | Download |
| 20 Feb 2018 | Informe anual de remuneraciones de los consejeros | ROVI releases the 2017 annual report regarding remuneration of the members of the Board of Directors | Download |
| 20 Feb 2018 | Informe Anual de Gobierno Corporativo | ROVI releases the 2017 Annual Corporate Governance Report | Download |
| 20 Feb 2018 | Otros sobre gobierno corporativo | The Company informs about the agreements adopted by the Board of Directors | Download |